GLP1R and Impaired glucose tolerance: Reduction in both islet glucagon and GLP-1 led to impaired glucose tolerance when challenged with an IPGTT (Fig. 5F), manifested by reduced insulin secretion both in vivo (Fig. 5G) and in perifused ex vivo islets (Fig. 5H).